{ "chinesename
许树昌
title
Prof.
surname
Hui
givenname
David SC
photo
../images/people/davidhui.png
education
MBBS (UNSW), MD (UNSW), MRCP (UK), FRCP (Lond, Edin, Glasg), FRACP, FHKCP, FHKAM (Medicine), FERS
post
Stanley Ho Professor of Respiratory Medicine
Chairman, Department of Medicine & Therapeutics
Director, Stanley Ho Centre for Emerging Infectious Diseases
Director, SH Ho Sleep Apnoea Management Center
Honorary Consultant Physician, Prince of Wales Hospital
researcherid
O-2754-2015
expertise
Respiratory Medicine
interest
Respiratory failure and sleep disordered breathing, management of emerging severe acute respiratory infections, safety of respiratory therapy and prevention of nosocomial infections in the post SARS era, common airway diseases.
tel
(852) 3505 3128
email
dschui@cuhk.edu.hk
research
Prof Hui’s research team has a strong track record in the study of exhaled air dispersion during application of different respiratory therapies, sleep disordered breathing, asthma, COPD, and clinical management of emerging severe acute respiratory infections.

selected
publication
Chan MT, Chow BK, Lo T, Ko FW, Ng SS, Gin T, Hui DS. Exhaled air dispersion during bag-mask ventilation and sputum suctioning - Implications for infection control. Sci Rep. 2018 Jan 9;8(1):198. " },{ "publication
Hui DS, Lee N, Chan PK, Beigel JH. The role of adjuvant immunomodulatory agents for treatment of severe influenza. Antiviral Res. 2018 Feb;150:202-216." },{ "publication
Hui DS, Azhar EI, Kim YJ, Memish ZA, Oh MD, Zumla A. Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission. Lancet Infect Dis. 2018 Aug;18(8):e217-e227." },{ "publication
Hui DS, Chow BK, Lo T, Tsang OTY, Ko FW, Ng SS, Gin T, Chan MT. Exhaled air dispersion during high flow nasal cannula therapy versus CPAP via different masks. Eur Respir J. 2019; Apr 11;53(4). pii: 1802339." },{ "publication
Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, Ippolito G, Mchugh TD, Memish ZA, Drosten C, Zumla A, Petersen E. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020 Feb;91:264-266." },{ "publication
Zumla A, Hui DS, Azhar EI, Memish ZA, Maeurer M. Reducing mortality from 2019-nCoV: host-directed therapies should be an option. Lancet. 2020 Feb 22;395(10224):e35-e36." },{ "publication
Guan WJ,* Ni ZY,* Hu Y,* Liang WH,* Ou CQ,* He JX,* Liu L,* Shan H,* Lei CL,* Hui DSC,* Du B,* Li LJ,* Zeng G,* Yuen KY,* Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. *co first authors with equal contribution to this paper." },{ "publication
Goldman JD, Lye DCB, Hui DS, Marks KM, Bruno R, Montejano R, Spinner CD, Galli M, Ahn MY, Nahass RG, Chen YS, SenGupta D, Hyland RH, Osinusi AO, Cao H, Blair C, Wei X, Gaggar A, Brainard DM, Towner WJ, Mu?oz J, Mullane KM, Marty FM, Tashima KT, Diaz G, Subramanian A; GS-US-540-5773 Investigators. Remdesivir for 5 or 10 Days in Patients with Severe Covid-19. N Engl J Med. 2020 Nov 5;383(19):1827-1837." },{ "publication
Wong SH, Teoh JYC, Leung CH, Wu WKK, Yip BHK, Wong MCS, Hui DSC. COVID-19 and Public Interest in Face Mask Use. Am J Respir Crit Care Med. 2020 Aug 1;202(3):453-455." },{ "publication
Ng SS, Wong VW, Wong GL, Chu WC, Chan TO, To KW, Ko FW, Chan KP, Hui DS. CPAP Did Not Improve Nonalcoholic Fatty Liver Disease in Patients with Obstructive Sleep Apnea: A Randomized Clinical Trial. Am J Respir Crit Care Med. 2021 Feb 15;203(4):493-501." }]}